心肌營(yíng)養(yǎng)素1(CT1)重組蛋白
Recombinant Cardiotrophin 1 (CT1)
CTF1
- 編號(hào)RPA810Ra01
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量25.3kDa
- 實(shí)際分子量26kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Met1~Ala203 (Accession # Q63086) with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)7.2
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1248¥ 3120¥ 6240¥ 18720¥ 46800
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
SDS-PAGE圖
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA810Ra01 | 心肌營(yíng)養(yǎng)素1(CT1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA810Ra01 | 心肌營(yíng)養(yǎng)素1(CT1)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA810Ra01 | 心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA810Ra71 | 心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAA810Ra81 | 心肌營(yíng)養(yǎng)素1(CT1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAA810Ra21 | 心肌營(yíng)養(yǎng)素1(CT1)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA810Ra | 心肌營(yíng)養(yǎng)素1(CT1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA810Ra | 心肌營(yíng)養(yǎng)素1(CT1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA810Ra01 | 心肌營(yíng)養(yǎng)素1(CT1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| European Journal of Preventive Cardiology | Exercise rescued chronic kidney disease by attenuating cardiac hypertrophy through the cardiotrophin-1 -> LIFR/gp 130 -> JAK/STAT3 pathway.[PubMed: 23064267] |
| Journal of Hypertension | Is There Any Additional Cardiotrophin 1 Increase With Obesity in Hypertensive Patients?: Pp. 12.466[Lww: Source] |
| Journal of Hypertension | Cardiotrophyn 1 Levels in Nondipper Hypertensive Patients: Pp. 12.464[Lww: Source] |
| American Journal of Hypertension | Association Between Cardiotrophin 1 Levels and Central Blood Pressure in Untreated Patients With Essential Hypertension[Pubmed: 24401751] |
| Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension[PubMed: 25747153] |
| Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension[PubMed: 25984599] |
| Food & Function | Pterostilbene improves glycaemic control in rats fed an obesogenic diet: involvement of skeletal muscle and liver[PubMed: 25998070] |
| International journal of cardiology | Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.[pubmed:27448535] |
| Soldan sa?a ?antl? do?umsal kalp hastal?kl? ?ocuklarda ?ant miktar? ile kardiyotrofin–1 ili?kisi[Doi: 10.5505/deutfd.2018.25338.30074] | |
| Annals?of?Nutrition?and?Metabolism | Effect of Salt Intake on the Serum Cardiotrophin-1 Levels in Chinese Adults[Pubmed: 30408810] |
| Atherosclerotic diseases | Cardiotrophin-1 and leptin as cardiovascular risk markers in male patients with obstructive sleep apnea syndrome[Pubmed: 30775602] |